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Novel glycopolymer hydrogels as mucosa-mimetic
materials to reduce animal testing†
Michael T. Cook,a Sarah L. Smithb and Vitaliy V. Khutoryanskiy*b
Glycopolymer hydrogels capable of mimicking mucosal tissue in
mucoadhesion testing have been designed. Liquid formulations
containing mucoadhesive polymers were found to be retained on
these tissues to the same extent as ex vivo gastric mucosa, when
using a dynamic method of assessing mucoadhesion.
Asmaterials chemistry has becomemore sophisticated, there has
been increasing success in the design of biomimetic systems.
In particular, hydrogels have great potential for use as mimics
of biological systems and organs.1 It is the aim of this study to
design hydrogels which are able to mimic mucosal tissue, for
use in mucoadhesion testing.
When drugs are administered by the oral, oromucosal, nasal,
ocular, rectal and vaginal routes, they must cross a ‘mucosal
membrane’ in the body in order to reach systemic circulation.
These ‘mucosal membranes’ are the wet linings covering the
gastrointestinal tract, airways, eyes, and reproductive tract, all
of which bear either secretory mucous, or membrane-bound
mucins.2 Secretory mucous is comprised of water (o95%),
mucins (o5%), inorganic salts (o1%), and other minor consti-
tuents.3 Membrane-bound mucins diﬀer in composition from
those found in secretory mucous, and contain hydrophobic
domains which anchor them to the epithelial surface.4 Mucins
are glycoproteins, bearing oligosaccharide side-chains, and have
a carbohydrate content of around 80%.5 The absorption of drugs
across mucosal membranes is typically poor, reducing drug
bioavailability.6 One strategy to improve drug uptake is the
use of ‘mucoadhesive’ polymeric materials, which improve the
retention of a dosage form at the surface of the mucosa.7
The assessment of mucoadhesive dosage forms is typically
conducted by measuring their adhesion to or retention on
ex vivo animal tissues. However, animal tissues may be diﬃcult
to source, can be highly heterogeneous, and often require the
sacrifice of an animal specifically for this tissue.8 A study
conducted within our group (unpublished) of 348 papers on
mucoadhesion published between 1998 and 2008 found that in
66% of the articles, laboratory animals were sacrificed specifically
for their mucosal tissue. It is the aim of this study to produce a
synthetic ‘mucosa-mimetic’ to be used as an alternative to ex vivo
mucosal tissue, which will allow a reduction in the number of
laboratory animals used in mucoadhesion testing, and provide
an easy to handle, more homogenous substrate. These materials
are based on glass-bound glycopolymer hydrogels, which may
be able to mimic the oligosaccharide chains of mucin. These oligo-
saccharides are arranged in a ‘bottle-brush’ structure, which
conceals the protein backbone.3 Glycopolymers, polymers bearing
pendant carbohydrate groups,9 have been shown to mimic
glycoproteins,10,11 including mucin,12,13 eﬀectively.
The mechanism of mucoadhesion is complex, but is in part
due to hydrogen bonding, electrostatics, and hydrophobic eﬀects
between mucoadhesive and mucosa.14 Solid dosage forms,
such as tablets, also adhere to mucosal membranes by wetting
of the dosage form, partial dehydration of the tissue, polymer
chain interpenetration,15 and chemical interactions.16 Liquid
and semi-solid mucoadhesives lack the dosage form hydration
and mucosa dehydration steps, and their adhesion to mucosal
membranes is driven by chemical interactions, viscosity, and
chain interpenetration.
Some attempts to use non-animal materials to study muco-
adhesion were focused on testing solid dosage forms by tablet
detachment from their surface (tensile testing). These studies
tested glass surfaces,17 polypropylene,18 and tanned leather19
with limited success. Previously we have demonstrated that
hydrogels are able to mimic porcine buccal mucosa in the
assessment of solid dosage forms (tablets) using tensile testing.
This ability of hydrogels to mimic buccal tissues correlated well
with the equilibrium swelling degree (ESD) of the materials, but
was also dependent on their chemical structure.8 Liquid and
semi-solid dosage forms containing mucoadhesive polymers are
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more commonly used for drug delivery to the eye (e.g. eye drops),
airways (nasal sprays) and some gastrointestinal formulations
(e.g. Gaviscons). Tang et al.20 reported the use of a dialysis
membrane to mimic a mucosal surface during the retention of
liquid and semi-solid peptide formulations; however, they did
not validate this substrate against biological mucosa. There is a
clear need in the development of artificial materials that could
be used as substrates to test retention of these formulations in
place of animal mucosal tissues. This study is the first report of
the successful design of hydrogel substrates to test liquid and
semi-solid mucoadhesive dosage forms.
In order to mimic the neutral sugars found in the side-chains
of mucins, a glycomonomer, N-acryloyl-D-glucosamine (AGA),
was synthesised by modification of an existing procedure.12
The structure of the product was confirmed by 1H NMR, 13C
NMR, FTIR, and mass spectroscopy. AGA can be copolymerised
with 2-hydroxyethylmethacrylate (HEMA) by thermally-initiated
radical polymerization in the presence of a cross-linker to produce
glycopolymer hydrogels. If this polymerization is conducted in
the presence of glass silanized so that it bears thiol groups on
its surface, then the gel can be covalently bound to the surface
of the glass (Scheme 1).21 This is due to the thiol acting as a
chain-transfer agent, allowing propagation of polymer chains
from the surface of the glass.22 Glass-bound glycopolymer
hydrogels were synthesised (Fig. 1b), composed of 20 mol%
AGA and 30 mol% AGA, with the remainder of the hydrogel
consisting of HEMA. 100 mol% HEMA hydrogels were also
synthesised as a control. The internal structure of the glyco-
polymer materials was highly porous (Fig. 1a), however, the
surface had no discernible porosity (Fig. S1, ESI†).
HR-MAS 1H NMR experiments on glycopolymer hydrogels
(Fig. 1c) confirmed the presence of both AGA and HEMA in the
hydrogel, and the absence of monomers. FTIR also confirmed the
presence of AGA in glycopolymer hydrogels, by the appearance
of amide carbonyl and C–N stretches at 1646 and 1544 cm1
(Fig. S2, ESI†). Elemental analysis revealed that the 20 mol% and
30 mol% AGA hydrogels had a final AGA content of 9.5 
0.4 mol% and 21.5  1.0 mol% AGA (Table 1). The deviation of
final hydrogel composition from the feed mixture is consistent
with reactivity ratios of HEMA and acrylamide found by
Kucharski and Lubczak,23 which indicate that in bulk, HEMA
radicals react preferentially with HEMA monomers rather than
acrylamide. The presence of increasing AGA in the hydrogels
led to an increased ESD of the gels (Table 1), with an associated
increase in thickness. A reduction in mechanical strength was
also observed (Fig. S3, ESI†), reflected in the reduction of the
elastic modulus of the materials (Table 1). The larger number of
hydrogen-bonding groups is the likely reason for this increase
in ESD, and reduction in strength. Furthermore, increasing
AGA concentration up to 40 mol% did not yield free-standing
hydrogels, but a viscous solution.
The rationale for testing if the glycomonomer hydrogels were
‘mucosa-mimetics’ or not was to see whether mucoadhesive poly-
mers were retained on their surface similarly to ex vivo mucosa.
In order to measure this, a flow-through system adapted from Cave
et al.24 was developed. Briefly, either a mucosal membrane or
hydrogel (the ‘testing substrate’) was placed onto a channel within
an incubator at 37 1C (Fig. 2ai). Then, mucoadhesive polymers
labelled with fluorescein were pipetted onto the testing substrate
(Fig. 2aii). An eluent of either PBS or a suitable simulated bodily
fluid was then passed over the testing substrate (Fig. 2aiii), washing
the mucoadhesive polymer from the surface. At defined volumes,
images were taken using a fluorescence stereomicroscope (Fig. 2aiv).
From these images, the fluorescence remaining on the testing
substrate can be measured, using the pixel intensity.
The tissues used in this study were porcine gastric mucosa
and bovine cornea, which represent mucosal membranes bearing
secretory mucous and membrane-bound mucins, respectively. The
mucoadhesive polymers chosen were chitosan and pectin, which
are commonly-used mucoadhesive agents.25,26 These polymers
were also chosen because they are basic and acidic, respectively,
so represent two diﬀerent classes of mucoadhesive materials.
Due to the diﬀerent functional groups present, two diﬀerent
methods had to be developed to label these polymers. Chitosan
was labelled with fluorescein isothiocyanate, as previously
described,27 whilst pectin was labelled with fluoresceinamine
using a developed protocol (ESI†). The eluents chosen to testScheme 1 Synthetic route to glass-bound glycopolymer hydrogels.
Fig. 1 (a) Glass-bound hydrogel’s internal structure by SEM (scale: 100 mm)
and (b) the whole sample (scale: 5 mm); (c) HR-MAS 1H NMR spectrum of a
30 mol% AGA hydrogel.
Table 1 Hydrogel composition and characteristics
I.D. % AGA
Thickness
(mm)
Elastic
modulus (kPa) ESD
100% HEMA N/A 2.0  0.2 24.3 2.24  0.21
20% AGA 9.5  0.4 3.5  0.5 13.7 4.94  0.02
30% AGA 21.5  1.0 3.9  0.3 6.7 13.1  2.70
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with were PBS, simulated gastric juice and simulated tear fluid
(ESI†). This testing rig allowed clear visualization of samples
that were either non-retentive, and those that retained muco-
adhesives on their surface (Fig. 2b). The retention of the two
mucoadhesive polymers on a control surface (PTFE), porcine
gastric mucosa, bovine cornea, or glass-bound hydrogels is shown
in Fig. 3. It can be seen that the retention of a mucoadhesive is
dependent on the type of polymer used, the eluent, and the
substrate onto which the mucoadhesive is placed. It was found
that the inclusion of AGA at diﬀerent ratios into the hydrogels
modulated the retention of polymers thereon. A 20 mol% AGA
glass-bound hydrogel was able to mimic porcine gastric tissue
in these tests with both PBS and simulated gastric solution,
showing no statistically significant diﬀerences from animal
mucosa using two-way ANOVA with Bonferroni post hoc test
(multiple comparisons, p o 0.05). The retention of a non-
mucoadhesive control, FITC-dextran, on 20 mol% AGA had no
statistically significant diﬀerence ( p 4 0.05) to gastric mucosa
using both PBS and SGJ (Fig. S4, ESI†). There was no correlation
found between any of the glass-bound hydrogels and bovine
cornea, including FITC-dextran control. It was found that 20 mol%
AGA mimicked bovine cornea when testing with simulated tear
fluid and chitosan ( p 4 0.05), but not in other conditions
( p o 0.05). 100 mol% HEMA and 30 mol% AGA were able to
mimic bovine cornea when testing in PBS with chitosan
( p4 0.05), but not in other conditions ( po 0.05). Comparison
of hydrogels and mucosal membranes to control experiments
(PTFE) showed that in every case the retention of mucoadhe-
sives was governed by more than rheological or solubility-based
eﬀects, which are cited as mechanisms by which muco-
adhesives adhere to mucosal membranes.28 It is likely that
the greater retention of chitosan on PTFE with STF is the result
of the poor solubility of chitosan in this eluent enhancing
hydrophobic interactions. In all non-control substrates and eluents
used, pectin appeared to be retained better than chitosan,
consistent with a study measuring their adhesion to porcine
intestinal mucosa.29 SEM images of hydrogels (Fig. S1, ESI†) and
mucosal membranes (Fig. S5, ESI†) revealed no similarity in
topology between the mucosa-mimetic 20 mol% AGA hydrogel
and porcine gastric mucosa surface features; the hydrogel
had no visible surface porosity at the magnifications used, and
was flat, whilst the mucosa was porous and highly irregular.
Mechanical testing (Fig. S3, ESI†) showed that the mucosa-
mimetic 20 mol% AGA hydrogel was stronger, with an elastic
modulus of 13.7 kPa, than porcine gastric mucosa, which has an
elastic modulus of only 1.5 kPa. Though this diﬀerence in
mechanical properties has not adversely aﬀected the 20 mol%
AGAs performance as a mucosa-mimetic in testing liquid
mucoadhesives, it must be considered if these materials were
to be used as a model in diﬀerent experiments. Due to the
diﬀerences in topology and mechanical properties of the testing
substrates, and non-dependence of rheological and solubility
eﬀects, it is likely that the reason that 20 mol% AGA hydrogels
are good mucosa-mimics for porcine gastric mucosa is similarity
of chemical interactions, which are the result of the incorpora-
tion of a glycomonomer into the hydrogel. These interactions are
likely hydrogen-bonding and hydrophobic interactions, as has
been investigated in the literature,26 though ion-dipole inter-
actions and electrostatics may also play a part.3 The presence of
Fig. 2 (a) Schematic diagram of retention testing rig, showing testing
substrate placement (i), application of mucoadhesive (ii), washing of surface
with syringe pump (iii) and microscopic analysis (iv); (b) exemplar micro-
graphs taken from retention experiments, showing a control (PTFE) with low
retention, and an example retentive sample (20 mol% AGA hydrogel); scale:
1 mm. Please note that the fluorescence micrographs have been cropped
and brightened by 50% for clarity.
Fig. 3 Retention profiles of either chitosan (left) or pectin (right) on testing
substrates during washing with either PBS, simulated gastric juice (SGJ),
or simulated tear fluid (STF). Data presented as mean  standard deviation,
n = 3; n.s. indicates no significant diﬀerence by t-testing, two-way ANOVA
has also been conducted (in text). Larger version in Fig. S6 (ESI†).
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glycomonomer pendant groups in the hydrogel may mimic the
oligosaccharides adorning the mucin glycoproteins present in
secretory mucin. N-Acetylglucosamine residues found in these
oligosaccharides4 bear particular similarity to AGA. In addition to
chemical interactions, physical entanglement aids mucoadhesion,6
thus the network structure also plays a role in determining
retention. 30 mol% AGA hydrogels were found to be poorer
mimics of the mucosae studied. Increasing AGA concentration
increased swelling degree, lowering the polymer volume fraction,
and loosening the network structure. It appears that there is
a careful balance needed between the chemical interactions
possible with the hydrogel, and the network structure present
which 30 mol% AGA does not meet. This is consistent with a
study of the adhesion of tablets to these materials,8 which also
used 10 and 15 mol% AGA hydrogels, and found that ESD
increased with increasing AGA, and that 20 mol% AGA had the
best mucosa-mimetic properties – using concentrations lower or
higher than this was detrimental, though this adhesion process
is also driven by dosage form hydration. Additionally, higher
water content has been associated with poor adhesion due to
overhydration of dosage forms.7 Retention of mucoadhesive
polymers on bovine cornea was lower than on porcine gastric
mucosa. This is likely the result of the lack of a secretory mucous
layer on the surface of the cornea. In gastric mucosa bearing
secretory mucous layers up to 450 mm thick,6 diffusion of
mucoadhesive into this mucous layer occurs, leading to chain
interpenetration, associated with improved mucoadhesion.30
The lack of a secretory mucus layer is likely to be the reason
why no mimic of the relatively hydrophobic cornea was found.
In conclusion, a material has been developed which is able
to mimic porcine gastric mucosa in mucoadhesion testing
experiments. This is based on a glass-bound hydrogel consisting
of 20 mol% AGA, and 80 mol% HEMA. The retention of muco-
adhesive polymers on the material was not significantly diﬀerent
from ex vivo mucosal membranes sourced from an abattoir.
Due to lack of similarity with topology and mechanical proper-
ties, it is believed that the ability to mimic mucosal tissue is due
to the presence of specific groups which are able to mimic the
large oligosaccharide content of the mucin glycoproteins pre-
sent in secretory mucous. This material could be used in the
pre-screening of mucoadhesive dosage forms, thus reducing
the number of lab animals used in mucoadhesion research.
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